RSV, also known as respiratory syncytial virus, is a prevalent virus affecting the respiratory system. It is normal for children to catch RSV at least once before they turn 2 or 3 years old, and for most, the symptoms are mild. However, for some, especially infants and young children, the virus can cause severe respiratory infections that may require hospitalization. RSV is the leading reason for hospitalization in babies with respiratory conditions.
Respiratory Syncytial Virus: The Signs and Symptoms of RSV
Respiratory viruses are frequently found in children under the age of 5, especially those who attend daycare or are exposed to tobacco smoke. Although most cases are mild, some children may develop respiratory syncytial virus (RSV) from a common cold or flu, leading to severe symptoms and requiring emergency department treatment or hospitalization.
High-risk patients include:
• Premature infants
• Babies less than six months
• Children suffering from reactive airway diseases like asthma
• Anyone with heart, lung, or compromised immune systems
RSV is a virus that usually spreads during the winter and early spring. It starts as a regular cold with upper respiratory symptoms. However, it can quickly move down to the lower respiratory tract, causing inflammation and infection in the lungs and air tubes. RSV can cause pneumonia and bronchiolitis, which can be dangerous for infants and children with asthma as it causes increased airway obstruction and difficulty breathing. In addition, RSV infections in young children can increase their risk of developing asthma later in life, although the reason behind this is still not clear. It could be because RSV damages the lungs or because the factors that put children at risk of asthma also put them at risk of RSV. RSV and other viruses can also increase the risk of developing allergies and sensitization to allergens. It is worth noting that RSV is not just a concern for infants and young children but also for adults with weakened immune systems, such as those with asthma, COPD, cancer, immunodeficiency, or autoimmune diseases.
Symptoms of RSV
Reach out to your child’s physician if any of the following symptoms occur. These could be indications that your youngster has developed RSV:
• Cold and flu symptoms lasting for more than ten days
• Symptoms return after they seem to clear up
• Tugging at an ear or an earache
• Wheezing and loud breathing
• Nostrils enlarging with each breath; quick breathing; skin above or below the ribs sucking with heavy breaths; bluish coloration around lips, skin, or fingernails.
• Severe headaches near the eyes or the back of the neck
• Constant vomiting
• Dehydration
Available Treatments for Respiratory Syncytial Virus
There is currently no cure for RSV. Instead, healthcare professionals focus on treatments that help reduce congestion and open the airways so patients can breathe better. Some of these treatments may include over-the-counter fever reducers and pain relievers. It is paramount to confer with your doctor to decide which medication best suits your child and follow age-appropriate dosage instructions carefully.
At-home remedies include:
• Staying hydrated
• Nasal saline drops
• Using a bulb syringe for younger children
• Lukewarm bath
Prevention Advice
RSV vaccines for adults 60 years and older and an RSV monoclonal antibody treatment for infants and young children are expected to be available in fall 2023. Upcoming vaccines for pregnant women and other age groups have been announced, offering a promising development. To prevent RSV infection, we recommended healthy lifestyle changes. It is important to note that the virus can persist on hard surfaces such as doorknobs and tabletops for several days and may spread rapidly through human contact, often before the infected person exhibits any obvious signs of the disease.
Frequently Asked Questions
Respiratory Syncytial Virus (RSV) is a common respiratory virus that primarily affects children under the age of 5, with nearly all children contracting it by age 2 or 3. While most cases cause mild symptoms similar to a cold, RSV can lead to severe respiratory infections, especially in infants, premature babies, and children with underlying health conditions.
Children with RSV may exhibit symptoms such as prolonged cold or flu signs lasting over ten days, wheezing, rapid breathing, nostrils flaring, chest retractions, bluish skin or lips, ear pain, constant vomiting, dehydration, and severe headaches. It is important to consult a physician if these symptoms occur, as they may indicate a more serious RSV infection.
High-risk children include premature infants, babies less than six months old, those with reactive airway diseases like asthma, and children with heart, lung, or compromised immune systems. These groups are more likely to experience severe complications from RSV that might require hospitalization.
There is no cure for RSV currently. Treatments focus on relieving symptoms, reducing congestion, and improving airway function. Typical care includes the use of over-the-counter fever reducers and pain relievers as advised by a doctor. Supportive at-home care like staying hydrated, using nasal saline drops, bulb syringes, and lukewarm baths also help ease symptoms.
RSV prevention includes maintaining healthy lifestyle habits, regular handwashing, and minimizing contact with infected individuals. RSV can persist on hard surfaces for several days, so disinfecting frequently touched areas is crucial. Promising new RSV vaccines for adults 60+ and monoclonal antibody treatments for infants became available in fall 2023, with further vaccines for other groups forthcoming.
RSV infections in young children can increase their risk of developing asthma and allergies later in life. This may be due to RSV-related lung damage or shared risk factors, but the exact reasons are still unclear. Hence, monitoring and managing RSV infections is important for long-term respiratory health.
While RSV primarily affects infants and young children, adults with weakened immune systems, such as those with asthma, COPD, cancer, immunodeficiency, or autoimmune diseases, are also at risk for severe RSV infections. This makes RSV an important consideration for vulnerable adult populations too.